Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.gastre.2020.06.005 http://scihub22266oqcxt.onion/10.1016/j.gastre.2020.06.005 C7546188!7546188!C7546188     free     free     free       ä-/-ä 2020 ; 43 (8): 472-80 Nephropedia Template TP {{tp|p=C7546188|t=2020. COVID-19 and liver disease: An update? |pdf=|usr=}}{{C7546188}} gab.com Text COVID-19 and liver disease: An update JO: ä-/-ä http://www.kidney.de/pget.php?&tw=1&pmid=C7546188 #FOAvip The SARS-CoV-2 pandemic has proven to be a serious challenge for the Spanish healthcare system. The impact of the virus on the liver is not well known, but in patients with chronic liver disease, mostly in advanced stages, it can critically compromise survival and trigger decompensation. Treatment in this subpopulation is complex due to the potential hepatotoxicity of some of the medicinal products used. Moreover, the pandemic has also negatively impacted patients with liver disease who have not contracted COVID-19, since the reallocation of human and material resources to the care of patients with the virus has resulted in a decrease in the treatment, diagnosis and follow-up of patients with liver disease, which will surely have negative consequences in the near future. Efficient reorganisation of hepatology units is a priority to minimise the impact of the pandemic on a population as vulnerable as liver disease patients. Twit Text FOAVip COVID-19 and liver disease: An update ????ä-/-ä http://www.kidney.de/pget.php?&tw=1&pmid=C7546188 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=C7546188 #FOAvip English Wikipedia <ref>{{Cite pmid|C7546188}}</ref> COVID-19 and liver disease: An update? #MMPMIDC7546188 Téllez L; Martín Mateos RM ä-/-ä 2020[Oct]; 43 (8): 472-80 PMIDC7546188show ga The SARS-CoV-2 pandemic has proven to be a serious challenge for the Spanish healthcare system. The impact of the virus on the liver is not well known, but in patients with chronic liver disease, mostly in advanced stages, it can critically compromise survival and trigger decompensation. Treatment in this subpopulation is complex due to the potential hepatotoxicity of some of the medicinal products used. Moreover, the pandemic has also negatively impacted patients with liver disease who have not contracted COVID-19, since the reallocation of human and material resources to the care of patients with the virus has resulted in a decrease in the treatment, diagnosis and follow-up of patients with liver disease, which will surely have negative consequences in the near future. Efficient reorganisation of hepatology units is a priority to minimise the impact of the pandemic on a population as vulnerable as liver disease patients. äCOVID-19 and liver disease: An update? (epmc).pdf DeepDyve Pubget Overpricing